Phase II study of front line therapy with nivolumab and salvage nivolumab + ipilimumab in patients with advanced renal cell carcinoma

Type of Cancer
Genito-Urinary

Sponsor
Hoosier

Protocol Number
CRN GU16-260

To Learn More Call
(201)-510-0950